2023
DOI: 10.1093/eurheartjsupp/suad028
|View full text |Cite
|
Sign up to set email alerts
|

Advanced heart failure: from definitions to therapeutic options

Abstract: Advanced heart failure (AHF) represents an ominous stage of heart failure (HF), where the expected prognosis remains poor regardless of the improvement in medical knowledge. In this review, we summarize the definition, prognosis, physiopathology, and clinical/therapeutic management of the disease, focusing on the fast and timely referral of the patient to the AHF facilities. We provide an insight of the diagnostic and therapeutic ‘work up’ performed in an Italian AHF hub, implying a deep phenotypical patients … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 27 publications
0
1
0
Order By: Relevance
“…Nevertheless, a potential role in remotely monitoring patients listed for HT is emerging. Elevated pulmonary vascular resistance, particularly if refractory to medical therapy, may represent a contraindication to HTx, depending on its severity [85]. No clinical experience regarding using a remote monitor in the "bridge to transplantation" strategy has been described.…”
Section: What Is the Role Of Remote Invasive Pressure Monitoring In A...mentioning
confidence: 99%
“…Nevertheless, a potential role in remotely monitoring patients listed for HT is emerging. Elevated pulmonary vascular resistance, particularly if refractory to medical therapy, may represent a contraindication to HTx, depending on its severity [85]. No clinical experience regarding using a remote monitor in the "bridge to transplantation" strategy has been described.…”
Section: What Is the Role Of Remote Invasive Pressure Monitoring In A...mentioning
confidence: 99%
“…Chronic heart failure (HF) is a clinical syndrome with high morbidity and mortality worldwide and a tremendous socioeconomic burden[ 1 , 2 ]. Depending on the development and progression of the disease, advanced stages are associated with a reduced survival[ 3 ]. The prevalence of HF in Europe appears to be 12% of adults, increasing with age from 1% for those aged < 55 years to > 10% in those aged 70 years or more, while the incidence is approximately 5/1000 person-years[ 4 , 5 ].…”
Section: Introductionmentioning
confidence: 99%